-
Exome_Sequencing__to_Identify_Causes_of_Leukaemia_Predisposing_Congenital_Neutropenias
Study
EGAS00001000100
-
MYCN Amplification and ATRX Mutations are Incompatible in Neuroblastoma
Study
EGAS00001003257
-
Genetic_factors_underlying_premature_coronary_heart_disease_in_patients_with_normal_coronary_arteries
Study
EGAS00001000133
-
Genetic characterization of B-cell prolymphocytic leukemia: a hierarchical prognostic model involving MYC and TP53 abnormalities - RNA-seq
Study
EGAS00001003274
-
Matched_Pair_Cancer_Cell_line_Whole_Genomes
Study
EGAS00001000160
-
Genetic characterization of B-cell prolymphocytic leukemia: a hierarchical prognostic model involving MYC and TP53 abnormalities - WXS
Study
EGAS00001003275
-
Assessment_of_genetic_and_epigenetic_variation_in_human_IPS_cells_RNA
Study
EGAS00001000367
-
Comparison of EGF and PDGF driven glioblastomas.
Study
EGAS00001001900
-
HipSci RNA sequencing for embryonic stem cell control lines
Study
EGAS00001001727
-
Genomic landscape of oral cancers (Complete Genomics WGS)
Study
EGAS00001002393
-
MutWP5__CRUK_Mutographs_of_Cancer__Breast__Reduction_Mammoplasty__Exome_
Study
EGAS00001003313
-
MutWP5__CRUK_Mutographs_of_Cancer__Breast__Reduction_Mammoplasty__WG_
Study
EGAS00001003311
-
Sequencing_probands_and_families_with_severe_insulin_resistance_syndromes
Study
EGAS00001000488
-
An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease
Study
EGAS00001001003
-
Genetic_screening__of_GPI_anchor_protein_synthesis__
Study
EGAS00001001256
-
Pediatric HGG WES and RNA-Seq
Study
EGAS00001005687
-
Determination_of_cell_specific_regulatory_enhancers_in_hematopoetic_models
Study
EGAS00001000586
-
Divergence between high metastatic tumor burden and low circulating tumor DNA concentration in metastasized breast cancer
Study
EGAS00001000625
-
Genome of the Netherlands
Study
EGAS00001000644
-
Combination_therapies_for_personalized_cancer_medicine
Study
EGAS00001000655
-
In this study, we performed exon sequencing (WXS) of 80 paired Brain cancer tumors and adjacent normal tissues to identify novel potential biomarkers. We extracted mutational signatures which induce somatic mutations . Our study covers a comprehensive genetic framework that can be used in clinical trials and treatment modalities in Brain cancer.
Study
EGAS00001002352
-
Comprehensive molecular profiling identifies novel genetic drivers and subtypes underlying medulloblastoma
Study
EGAS00001001953
-
The Asian Diversity Project: genotyping of 37 Asian populations and ethnic groups
Study
EGAS00001002100
-
miRNA_expression_in_response_to_LPS_stimulus_in_macrophages
Study
EGAS00001000691
-
CEHM
Study
EGAS00001002366